$AFCG

TANNENBAUM LEONARD M purchased $66K of AFCG

TANNENBAUM LEONARD M purchased 20,000 shares of Advanced Flower Capital Inc. (AFCG) at $3.29 on 2026-08-20.

Original reporting
SEC EDGAR · TANNENBAUM LEONARD M
Published Aug 21, 2026, 8:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AFCG
Neutral
high confidence
Mentioned
$AFCG
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFCGNeutralLow
01

Why it matters

The insider purchase adds modest confidence but is unlikely to move the stock significantly given its size.

02

Market read

Routine insider transaction with limited trading relevance.

03

What to watch

Potential upcoming financing or partnership not yet announced could be influencing insider confidence.

Relevance 4/10Novelty 4/10Timing: transaction date 2026-08-20

Background

Advanced Flower Capital Inc. (AFCG) is a publicly traded cannabis company. The filing reports a direct purchase by a director who already holds a 10% stake.

Company-level read

Ticker impact

$AFCGNeutralHigh confidence
Context

Director Leonard Tannenbaum purchased 20,000 shares of Advanced Flower Capital Inc. for $65,800 on 2026-08-20, increasing his holdings to 6,595,445 shares.

Expected impact

Limited short-term impact; may provide slight support if market perceives insider confidence.

Evidence & confidence

Form 4 filing is the first public disclosure of the purchase; however, the amount is under $1M, typical for routine insider activity.

Market effects

Minimal effect on the cannabis sector; insider activity is routine.

No broader regional impact.

Not globally relevant.

Counterpoint

The purchase could be a strategic move ahead of undisclosed corporate actions, suggesting potential upside.

Key entities

  • Advanced Flower Capital Inc.

    Issuer of the Form 4 filing.

  • Leonard Tannenbaum

    Director and 10% owner of AFCG.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFCGMed

Advanced Flower Capital (AFCG) Q2 2026 Earnings Call Transcript

Advanced Flower Capital (AFCG) reported Q2 2026 net investment income of $3.5M, or $0.15 per share, with NAV per share rising to $8.25. The company repurchased 839,406 shares and has a $1.3B investment pipeline. Management highlighted rising default rates in private credit and challenges in the cannabis industry. AFCG is resolving nonaccrual loans and focusing on lower middle market borrowers.

$AFCGMed

Advanced Flower Capital Inc. (AFCG): Results of Operations and Financial Condition

Advanced Flower Capital Inc. (AFCG) filed an SEC Form 8-K — Results of Operations and Financial Condition. AFC Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net investment income (“NII”) of $3.5 million, or $0.15 per weighted average share WEST PALM BEACH, FL, August 13, 2026 – Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) tod

$AFCGMed

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) said it committed $7.0 million to a $25.0 million senior secured credit facility, including a term loan and delayed draw term loan. An AFC affiliate will add $5.0 million, for $12.0 million total. Proceeds will refinance existing capital and fund acquisitions for an outpatient behavioral health platform. The facility has a four-year term.